Naloxone

General

  • Type: Opioid antagonists, antidote
  • Dosage Forms:
  • Common Trade Names: Narcan

Adult Dosing

Opioid toxicity

  • Bolus (May repeat q3min up to max dose 10mg)
    • Apneic or near-apneic - 2mg IV
    • Opioid-naive with minimal respiratory depression - 0.4mg IV
    • Opioid-dependent with minimal respiratory depression - 0.05mg IV
  • Infusion
    • Only give if the patient responded to the bolus and required repeat administration
    • Step 1: Determine the "wake-up dose" or bolus required to wake the pt
    • Step 2: Give 2/3 of the "wake-up dose" per hr; mix in 1L D5W
  • Intranasal
    • Pre-mixed nasal spray: 3,4, or 8 mg (1 spray) in one nostril. May repeat q 2-3 minutes if no response
    • IV solution: 2 mg (1 mg each nostril using atomizer)[1]

Pediatric Dosing

  • Full reversal (overdose or intoxication)
    • IV/IO: 0.1 mg/kg (max 2 mg). Repeat every 2 to 3 minutes as needed
  • Titrated correction of respiratory depression from therapeutic opioid
    • IV/IM/SUBQ: 0.005 to 0.01mg/kg IV every 2 to 3 minutes as needed to desired degree of reversal

Special Populations

  • Pregnancy Rating: C
  • Lactation: insufficient data
  • Renal Dosing: No dose adjustment
  • Hepatic Dosing: No dose adjustment

Contraindications

  • Allergy to class/drug

Adverse Reactions

Pharmacology

  • Metabolism: hepatic
  • Excretion: renal
  • Mechanism of Action: opioid antagonist (competes for mu receptor binding sites, displacing opioid)
  • Onset of action - 1-2min
  • Duration of action - 20-90min (may be less than that of the ingested opioid)
  • For this reason many hospital algorithms call for ~3 hours of ED observation prior to discharge
  • Some small studies have called for decreasing this time frame to 1 hour but there are often adverse events in a significant proportion of these patients (one study showed that 15% of patients had adverse events such as need for supplemental oxygen after attempting discharge at 1 hour)[3].

See Also

References

  1. Naloxone. In: Lexi-Drugs. UpToDate Inc; 2025. Accessed September 30, 2025. https://www.uptodate.com/contents/naloxone-drug-information
  2. Mechanism for Naloxone-Related Pulmonary Edema in Opiate or Opioid Overdose Reversal. August 2015. EBM Consult. https://www.ebmconsult.com/articles/mechanism-naloxone-related-pulmonary-edema-opiate-opioid-overdose-reversal.
  3. Hospital Observation Upon Reversal (HOUR) With Naloxone: A Prospective Clinical Prediction Rule Validation Study Clemency, B.M., et al, Acad Emerg Med 26(1):7, January 2019